U.S. markets closed

Constellation Pharmaceuticals, Inc. (CNST)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
22.82+0.11 (+0.48%)
At close: 4:00PM EDT

22.82 0.00 (0.00%)
After hours: 4:15PM EDT

Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Annual
Quarterly
Premium required to access monthly data
Monthly
Subscribe to Premium to download historical data
 
As of Date: 10/17/2020
Current
6/30/20203/31/202012/31/20199/30/2019
Market Cap (intraday) 5
1.10B1.26B1.31B1.58B166.81M
Enterprise Value 3
617.59M943.38M971.19M1.53B100.67M
Trailing P/E
N/AN/AN/AN/A0.42
Forward P/E 1
N/AN/AN/AN/AN/A
PEG Ratio (5 yr expected) 1
N/AN/AN/AN/AN/A
Price/Sales (ttm)
N/AN/AN/AN/AN/A
Price/Book (mrq)
2.334.523.8940.822.49
Enterprise Value/Revenue 3
N/AN/AN/AN/AN/A
Enterprise Value/EBITDA 6
-6.39-32.81-39.75-66.24-4.95

Trading Information

Stock Price History

Beta (5Y Monthly) 2.90
52-Week Change 351.30%
S&P500 52-Week Change 314.38%
52 Week High 359.49
52 Week Low 311.66
50-Day Moving Average 321.69
200-Day Moving Average 329.49

Share Statistics

Avg Vol (3 month) 3521.95k
Avg Vol (10 day) 3331.52k
Shares Outstanding 547.5M
Float 28.01M
% Held by Insiders 12.15%
% Held by Institutions 199.53%
Shares Short (Sep 29, 2020) 44.96M
Short Ratio (Sep 29, 2020) 48.79
Short % of Float (Sep 29, 2020) 415.27%
Short % of Shares Outstanding (Sep 29, 2020) 410.43%
Shares Short (prior month Aug 30, 2020) 43.6M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2019
Most Recent Quarter (mrq)Jun 29, 2020

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-19.39%
Return on Equity (ttm)-37.30%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -100.02M
Net Income Avi to Common (ttm)-100.56M
Diluted EPS (ttm)-2.77
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)520.51M
Total Cash Per Share (mrq)10.96
Total Debt (mrq)39.9M
Total Debt/Equity (mrq)8.45
Current Ratio (mrq)19.17
Book Value Per Share (mrq)9.94

Cash Flow Statement

Operating Cash Flow (ttm)-83.13M
Levered Free Cash Flow (ttm)-47.46M